SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
Analysts Say Valeant Pharmaceuticals International/Allergan Inc. Deal Could Lead To Buying Spree
September 29, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Valueact Places CEO On Valeant Pharmaceuticals International’s Board In Effort To Force Allergan Inc. Takeover
September 26, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
More Than 35% Of Allergan Inc. Investors Demand Special Meeting; Support For Valeant Merger Grows
September 12, 2014
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Allergan Inc. Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International Bid
August 22, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Allergan Inc. Approaches Salix Pharmaceuticals, Ltd. To Fend Off Valeant Pharmaceuticals International’s Hostile Bid
August 20, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Allergan Inc. CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International
August 19, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
SEC Investigating Valeant Pharmaceuticals International, Pershing Square’s Hostile Takeover Bid For Allergan Inc.
August 15, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
Allergan Inc. Claims Bill Ackman, Valeant Pharmaceuticals International Hatched Improper Insider Trading Scheme
August 4, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
BioCapital
Insiders Reveal Valeant Pharmaceuticals International’s Cost Cutting May Have Gone Too Far
July 31, 2014
 · 
1 min read
Load More
IN THE PRESS
FDA
Actavis, Valeant Win FDA Approval for VIBERZI to Treat IBS With Diarrhea
May 28, 2015
 · 
6 min read
Valeant Announces 2015 Annual Meeting Results
May 20, 2015
 · 
1 min read
Valeant To Webcast 2015 Annual Meeting Of Shareholders
May 13, 2015
 · 
1 min read
Business
Valeant Reports First Quarter 2015 Financial Results
April 29, 2015
 · 
5 min read
Business
Valeant CFO To Step Down
April 29, 2015
 · 
5 min read
Valeant Release: RELISTOR Receives Positive CHMP Opinion In The EU For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-Cancer Pain
April 24, 2015
 · 
8 min read
Policy
Allergan, Valeant and Ackman Finally End Fight Over Failed Buyout
April 13, 2015
 · 
1 min read
Business
Valeant To Announce 2015 First Quarter Results On April 29, 2015
April 9, 2015
 · 
1 min read
Redemption Of All Of Salix’s Outstanding 6.00% Senior Notes Due 2021
April 1, 2015
 · 
3 min read
Deals
Valeant Completes Acquisition Of Salix
April 1, 2015
 · 
1 min read
Load More